CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0119 | -7.06231454006 | 0.1685 | 0.1849 | 0.1522 | 2787805 | 0.16596473 | CS |
4 | 0.0236 | 17.7443609023 | 0.133 | 0.209 | 0.125 | 2268820 | 0.15793361 | CS |
12 | 0.0166 | 11.8571428571 | 0.14 | 0.209 | 0.111 | 2187698 | 0.14109992 | CS |
26 | -0.0054 | -3.33333333333 | 0.162 | 0.315 | 0.111 | 2250785 | 0.15726246 | CS |
52 | -0.0304 | -16.256684492 | 0.187 | 0.418 | 0.111 | 2435495 | 0.1783938 | CS |
156 | -2.1534 | -93.2207792208 | 2.31 | 2.43 | 0.111 | 2198521 | 0.42531039 | CS |
260 | -0.1784 | -53.2537313433 | 0.335 | 10.01 | 0.111 | 3037310 | 2.06105589 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.